FABP4 and rheumatoid arthritis: The increase in FABP4 was regulated by the mammalian target of rapamycin complex 1 (mTORC1) pathway to promote synovitis, angiogenesis, and cartilage degeneration, which exacerbated the severity of experimental RA.